| CAT. No. | CP-T10002 |
|---|---|
| CAS. No. | 1197-17-7 |
| Mol. F. | C8H15NO2 |
| Mol. Wt. | 157.21 |
| Stock Status | In Stock |
Tranexamic Acid EP Impurity B, also known as cis-Tranexamic Acid and Tranexamic Acid USP Related Compound B, is a structurally characterized impurity of Tranexamic Acid, chemically identified as (1s,4s)-4-(aminomethyl)cyclohexane-1-carboxylic acid. Chemicea supplies this impurity reference standard with comprehensive analytical characterization data to support pharmaceutical quality, regulatory, and research requirements.
Tranexamic Acid EP Impurity B/USP RC B/cis-Tranexamic Acid helps pharmaceutical companies identify, quantify, and monitor impurities, ensuring product quality and regulatory compliance.
Tranexamic Acid EP Impurity B/USP RC B/cis-Tranexamic Acid can be analyzed using HPLC, UPLC, LC-MS, GC-MS (where applicable), and other advanced chromatographic and spectroscopic techniques.
Yes, Tranexamic Acid EP Impurity B/USP RC B/cis-Tranexamic Acid is widely used as a reference standard for qualitative and quantitative analysis of impurities in pharmaceutical products.
It assists in establishing specificity, accuracy, precision, linearity, detection limits, and quantification limits during analytical method validation studies.
Tranexamic Acid EP Impurity B/USP RC B/cis-Tranexamic Acid can be sourced from Chemicea, a trusted supplier of pharmaceutical impurities, reference standards, metabolites, and analytical research materials for the pharmaceutical industry.
Tranexamic Acid EP Impurity B/USP RC B/cis-Tranexamic Acid may form during the synthesis, purification, storage, or degradation of the parent drug substance under specific process or environmental conditions.
The CAS number for Tranexamic Acid EP Impurity B/USP RC B/cis-Tranexamic Acid is 1197-17-7.